Poehling Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.48M | Buy |
23,345
+527
| +2% | +$55.9K | 0.58% | 49 |
|
|
2025
Q1 | $2.83M | Sell |
22,818
-164
| -0.7% | -$20.4K | 0.72% | 45 |
|
|
2024
Q4 | $2.83M | Buy |
22,982
+11
| +0% | +$1.36K | 0.7% | 43 |
|
|
2024
Q3 | $2.56M | Buy |
22,971
+1,280
| +6% | +$143K | 0.65% | 50 |
|
|
2024
Q2 | $2.32M | Buy |
21,691
+805
| +4% | +$85.9K | 0.63% | 48 |
|
|
2024
Q1 | $2.52M | Buy |
20,886
+2,170
| +12% | +$261K | 0.67% | 45 |
|
|
2023
Q4 | $2.3M | Buy |
18,716
+11,952
| +177% | +$1.47M | 0.73% | 46 |
|
|
2023
Q3 | $876K | Sell |
6,764
-609
| -8% | -$78.8K | 0.31% | 69 |
|
|
2023
Q2 | $914K | Buy |
+7,373
| New | +$914K | 0.31% | 72 |
|
|
2022
Q3 | – | Sell |
-8,343
| Closed | -$1.3M | – | 120 |
|
|
2022
Q2 | $1.3M | Sell |
8,343
-210
| -2% | -$32.8K | 0.49% | 53 |
|
|
2022
Q1 | $1.33M | Sell |
8,553
-3,237
| -27% | -$504K | 0.41% | 62 |
|
|
2021
Q4 | $1.5M | Buy |
11,790
+728
| +7% | +$92.7K | 0.48% | 60 |
|
|
2021
Q3 | $1.44M | Buy |
+11,062
| New | +$1.44M | 0.49% | 62 |
|